Abstract:Objective To prepare monoclonal antibody (mAb) against human cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) and identify the immunological characteristics of the mAb. Methods The recombinant human CYFRA21-1 protein was used as antigen to immunize BALB/c mice. The mouse spleen cells with the highest sera titer were fused with SP2/0 myeloma cells. The positive hybridoma cells were screened by indirect ELISA, and the isotypes of the mAb was detected. The hybridoma cell lines producing IgG1 were injected intraperitoneally into mouse to produce high quantities mAb. Immunoglobulin was purified from ascites using protein G affinity chromatography. The titers of prepared mAb were determined by indirect ELISA. The immunological characteristics were determined by Western blot and competitive ELISA respectively. Then clinical application study about the prepared mAb was assessed. Results Two strains of hybridoma cells (2G8 and 12G7) were generated. They could stably secrete mAb against human CYFRA21-1 which belonged to the IgG isotype and contained the κ light chain. Two strain mAb (2G8 and 12G7) exhibited high specificity for CYFRA21-1 and did not react with the other analogues. The titers of 2G8 and 12G7 were 1 × 10 -6 and 5 × 10 -7 separately. The correlation of between the results of CYFRA21-1 detection in 134 serum samples by the developed competitive ELISA based on the prepared mAbs and CYFRA21-1 CLIA Test Kit (Beijing Yuande Bio-Medical Engineering Co., LTD) were y = 0.8167 x + 0.3755 (r = 0.9772) and y = 0.8142 x + 0.3655 (r = 0.9770) respectively. Conclusions The monoclonal antibody against human CYFRA21-1 with high titer and specificity has been successfully prepared, which provided a foundation for completing localization of quantitative detection kit of human serum CYFRA21-1.

Preparation and characterization of monoclonal antibodies against mouse Metrnl

Microsoft Word-Yuan et al PDF

[Preparation and Characterization of Monoclonal Antibody Against Human Telomeric Repeat Binding Factor 1].

Preparation and characterization of a novel monoclonal antibody against human PD-1

[Preparation of Monoclonal Antibodies Against Human Mesenchymal Stem Cells].

Preparation and Characterization of Monoclonal Antibodies Against Mouse Estrogen-Enhanced Transcript

Preparation and Characterization of Monoclonal Antibody Against Human Angiopoietin-Like Protein 2

Preparation and Identification of Monoclonal Antibody Against Cytolysin of Vibrio Vulnificus

Preparation and Characterization of Monoclonal Antibody Against Human LSECtin

Preparation and Identification of Monoclonal Antibodies Against Humanin

Preparation of anti-human esophageal cancer invasion and metastasis functional monoclonal antibody

Preparation and Characterization of Monoclonal Antibody Against M.hyorhinis

Preparation and Preliminary Utilization of Monoclonal Antibodies Specifically Against Extracellular Peptide Fragment of Prostate Specific Membrane Antigen

[Preparation and assessment of a monoclonal antibody against mouse NLRP3]

Preparation and characterization of monoclonal antibodies against human cytokeratin 19 fragment antigen 21-1

Preparation and Characterization of Monoclonal Antibodies Against VSTM1.

Preparation and Characterization of Monoclonal Antibodies Against Recombinant Human NDPK-A

[Preparation and identification of mouse-derived monoclonal antibodies to human ST2 molecule].

[Preparation and Characterization of Monoclonal Antibodies Against CMTM7].

Preparation and Characterization of a Monoclonal Antibody Against Human B Lymphocyte Stimulator

Polyclonal Antibody Preparation and Characterization of Mouse Rnf141